Regeneron drops after skin cancer treatment misses late-stage trial goal

May 18 (Reuters) - Shares of Regeneron fell 11.8% premarket on Monday after the company's experimental treatment missed the ...

Moderna, Merck cancer combo cuts melanoma spread risk at five years

May 21 () - Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another ‌part ...
The Herald-Dispatch

New treatment for nonmelanoma skin cancer offered in Barboursville

Amy A. Vaughan, M.D. Dermatology introduces Gentlecure, the most advanced nonsurgical treatment for nonmelanoma skin cancer, offering convenient and effective therapy with Image-Guided Superficial ...
AOL

New personalized skin cancer treatment shows success in preventing return of high-risk melanoma

A new personalized skin cancer treatment is showing success in preventing the return of high-risk melanoma. Five-year study results were announced on Tuesday by pharmaceutical companies Moderna Inc ...
KOAA News5

May is Skin Cancer Awareness Month: What you should know to stay protected

A Colorado skin specialist shares what everyone should know about sun safety, early detection, and protecting yourself this ...

Regeneron drops after skin cancer treatment fails late-stage trial

Regeneron's shares fell 12% in morning trade on Monday after the company's experimental treatment missed the main ‌goal in a ...